Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly vs Daily Risedronate in Postmenopausal Osteoporosis
NCT00247273Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Oct 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of risedronate in postmenopausal osteoporosis, sponsored by Warner Chilcott. Started Oct 2005; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00247273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247273.